title: Reply to Xu—Oral Anticoagulants, Health Technology Assessment, and Health Policy.
authors.forename: James A
authors.initials: JA
authors.lastname: Stone
authors.forename: Mukul
authors.initials: M
authors.lastname: Sharma
authors.forename: Karen M
authors.initials: KM
authors.lastname: Earl
mesh_terms: D000925:Anticoagulants / Q000191:economics*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D019983:Guideline Adherence / Q000191:economics*; D006801:Humans; D017410:Practice Guidelines as Topic; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants